Nasdaq News

(RTTNews) - Artelo Biosciences (ARTL), a clinical-stage pharmaceutical company focused on lipid-signaling pathways, announced that it has been selected to deliver its first company presentation at BIO-Europe 2026 in Cologne, Germany.

"He hasn't picked up a basketball since..." My fellow dad winced slightly, and I completed the sentence for him.

Key PointsWorkiva develops software that helps large organizations aggregate data for the purpose of managing their regulatory compliance obligations.

(RTTNews) - SciSparc Ltd. (SPRC), through its majority-owned subsidiary NeuroThera Labs (NTLX.V), announced that subsidiary CliniQuantum reported successful quantum-enabled analysis of billions of gene combinations using real-world clinical data.

(RTTNews) - Nestlé SA (NSTR.L, NESN.SW) and the National Basketball Association, or NBA, have announced a new, multi-year marketing partnership making Milo, Nescau, and Nesquik official partners of the NBA with effect from January 1, 2027.

Key PointsTesla reported a quarterly beat in vehicle deliveries for the second quarter in a row.

Key PointsIndustry news reported that Intel would be hiking PC CPU prices in October.

Key PointsCrowdStrike remains a leader in cloud-native endpoint security with robust revenue growth despite past operational challenges.

Key PointsiShares U.S. Consumer Staples ETF has a lower expense ratio and much larger assets under management than Invesco S&P 500 Equal Weight Consumer Staples ETF.

Key PointsAnthropic is growing at a rate that is far faster than SpaceX's.

Key PointsAmerican Express has been one of Berkshire Hathaway’s best long-term compounders.

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo

(RTTNews) - Wednesday, Ultragenyx Pharmaceutical Inc. (RARE) said it has entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for $210 million.

(RTTNews) - Wednesday, AbbVie Inc. (ABBV) announced that the U.S. Food and Drug Administration has granted two Breakthrough Therapy Designations for telisotuzumab adizutecan or Temab-A in colorectal cancer and non-small cell lung cancer.

Key PointsNike stock has taken a beating, in part due to poor business performance in China.

Key PointsThe iShares U.S. Financials ETF (IYF) provides broad exposure to the financial sector, whereas the State Street SPDR Bank ETF (KBE) focuses narrowly on the banking industry.

The S&P 500 Index ($SPX ) (SPY ) closed up by +0.58% on Tuesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.48%. December E-mini S&P futures (ESZ26 ) rose +0.61%, and December E-mini...

CrowdStrike (NASDAQ: CRWD) sits at the center of a fast-growing collision between AI and cybersecurity. Falcon adoption, expanding ARR, and rising demand for AI security could support a much larger business, but the path to $500 requires strong growth, higher GAAP margins, and a

Key PointsPalantir has become an important AI operating system and is seeing rapid revenue growth as a result.

This morning a "Potential Dividend Run Alert" went out for LTC Properties, Inc. (NYSE: LTC), at our DividendChannel.com Dividend Alerts service (a free email alerts feature). Let's look at the situation in greater detail, shall we? First of all, what is a "Dividend Run" anyway?